235 related articles for article (PubMed ID: 16716781)
1. Post-genomic vaccine development.
Serruto D; Rappuoli R
FEBS Lett; 2006 May; 580(12):2985-92. PubMed ID: 16716781
[TBL] [Abstract][Full Text] [Related]
2. Genome-based approaches to develop vaccines against bacterial pathogens.
Serruto D; Serino L; Masignani V; Pizza M
Vaccine; 2009 May; 27(25-26):3245-50. PubMed ID: 19200820
[TBL] [Abstract][Full Text] [Related]
3. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
[TBL] [Abstract][Full Text] [Related]
4. Developing antibacterial vaccines in genomics and proteomics era.
Kaushik DK; Sehgal D
Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
[TBL] [Abstract][Full Text] [Related]
5. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
Mora M; Donati C; Medini D; Covacci A; Rappuoli R
Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
[TBL] [Abstract][Full Text] [Related]
6. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
Seib KL; Zhao X; Rappuoli R
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
[TBL] [Abstract][Full Text] [Related]
7. The impact of genomics on vaccine design.
Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
[TBL] [Abstract][Full Text] [Related]
8. Bacterial proteomics and identification of potential vaccine targets.
Walters MS; Mobley HL
Expert Rev Proteomics; 2010 Apr; 7(2):181-4. PubMed ID: 20377385
[TBL] [Abstract][Full Text] [Related]
9. Integrated approaches to therapeutic target gene discovery.
DeFife KM; Wong-Staal F
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):683-9. PubMed ID: 12630288
[TBL] [Abstract][Full Text] [Related]
10. Reverse vaccinology and genomics.
Rappuoli R; Covacci A
Science; 2003 Oct; 302(5645):602. PubMed ID: 14576423
[TBL] [Abstract][Full Text] [Related]
11. Vaccines in the era of genomics: the pneumococcal challenge.
Barocchi MA; Censini S; Rappuoli R
Vaccine; 2007 Apr; 25(16):2963-73. PubMed ID: 17324490
[TBL] [Abstract][Full Text] [Related]
12. Assigning functions to genes--the main challenge of the post-genomics era.
Janitz M
Rev Physiol Biochem Pharmacol; 2007; 159():115-29. PubMed ID: 17846923
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
Poland GA; Ovsyannikova IG; Jacobson RM; Smith DI
Clin Pharmacol Ther; 2007 Dec; 82(6):653-64. PubMed ID: 17971814
[TBL] [Abstract][Full Text] [Related]
14. Towards a universal group B Streptococcus vaccine using multistrain genome analysis.
Tettelin H; Medini D; Donati C; Masignani V
Expert Rev Vaccines; 2006 Oct; 5(5):687-94. PubMed ID: 17181441
[TBL] [Abstract][Full Text] [Related]
15. Genome-derived vaccines.
De Groot AS; Rappuoli R
Expert Rev Vaccines; 2004 Feb; 3(1):59-76. PubMed ID: 14761244
[TBL] [Abstract][Full Text] [Related]
16. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
Rachman H; Kaufmann SH
Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
[TBL] [Abstract][Full Text] [Related]
17. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
18. Genomics and vaccine development.
Gay CG; Zuerner R; Bannantine JP; Lillehoj HS; Zhu JJ; Green R; Pastoret PP
Rev Sci Tech; 2007 Apr; 26(1):49-67. PubMed ID: 17633293
[TBL] [Abstract][Full Text] [Related]
19. Genome- and proteome-wide screening strategies for antigen discovery and immunogen design.
Schussek S; Trieu A; Doolan DL
Biotechnol Adv; 2014; 32(2):403-14. PubMed ID: 24389084
[TBL] [Abstract][Full Text] [Related]
20. In silico and microarray-based genomic approaches to identifying potential vaccine candidates against Leptospira interrogans.
Yang HL; Zhu YZ; Qin JH; He P; Jiang XC; Zhao GP; Guo XK
BMC Genomics; 2006 Nov; 7():293. PubMed ID: 17109759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
